4D Path Unveils Oncology Platform for Biomarker Profiling and Cancer Diagnosis
shot by IP News Shots / 12:36 pm on 16 November, 2020
4D Path, a company conceived by experts from Harvard Medical School, MIT and University of Cambridge, has revealed a more efficient and faster approach for cancer diagnosis and biomarker profiling that speeds up and democratizes precision medicine for both clinical trials and optimized patient care. The company applies its cloud-based, quantitative approach to find the data previously hidden in an H&E biopsy image.
Industry: Healthcare Equipment & Supplies | Type of IP: Products & Platforms